Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Cash from Investing Activities (2021 - 2025)

Historic Cash from Investing Activities for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to -$62.3 million.

  • Molecular Partners Ag's Cash from Investing Activities fell 7585.77% to -$62.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.1 million, marking a year-over-year decrease of 967.4%. This contributed to the annual value of $46.0 million for FY2024, which is 854.74% down from last year.
  • According to the latest figures from Q3 2025, Molecular Partners Ag's Cash from Investing Activities is -$62.3 million, which was down 7585.77% from $60.3 million recorded in Q2 2025.
  • Molecular Partners Ag's 5-year Cash from Investing Activities high stood at $113.3 million for Q3 2022, and its period low was -$113.7 million during Q2 2022.
  • Over the past 5 years, Molecular Partners Ag's median Cash from Investing Activities value was $3643.5 (recorded in 2023), while the average stood at -$1.9 million.
  • Within the past 5 years, the most significant YoY rise in Molecular Partners Ag's Cash from Investing Activities was 117574.61% (2022), while the steepest drop was 2233161.54% (2022).
  • Over the past 5 years, Molecular Partners Ag's Cash from Investing Activities (Quarter) stood at -$24.1 million in 2021, then crashed by 335.29% to -$104.8 million in 2022, then surged by 147.98% to $50.3 million in 2023, then decreased by 8.21% to $46.2 million in 2024, then tumbled by 235.05% to -$62.3 million in 2025.
  • Its Cash from Investing Activities was -$62.3 million in Q3 2025, compared to $60.3 million in Q2 2025 and $38887.6 in Q1 2025.